Benefit of Early Protocol Biopsy and Treatment of Subclinical Rejection
Status:
Completed
Trial end date:
2006-01-01
Target enrollment:
Participant gender:
Summary
This multicentre randomized, controlled trial (RCT) compared renal allograft histology and
function in subjects treated with Tacrolimus + MMF + prednisone undergoing early protocol
biopsies and treatment of subclinical rejection versus a non-protocol biopsy control group.